Aurinia Pharmaceuticals, Inc. (AUPH)
16.10
-0.01
(-0.06%)
USD |
NASDAQ |
Sep 11, 16:00
16.10
0.00 (0.00%)
After-Hours: 06:06
Aurinia Pharmaceuticals Market Cap : 2.140B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.140B |
| September 10, 2026 | 2.141B |
| September 09, 2026 | 2.160B |
| September 08, 2026 | 2.136B |
| September 04, 2026 | 2.137B |
| September 03, 2026 | 2.142B |
| September 02, 2026 | 2.165B |
| September 01, 2026 | 2.133B |
| August 31, 2026 | 2.141B |
| August 28, 2026 | 2.165B |
| August 27, 2026 | 2.190B |
| August 26, 2026 | 2.198B |
| August 25, 2026 | 2.226B |
| August 24, 2026 | 2.202B |
| August 21, 2026 | 2.213B |
| August 20, 2026 | 2.295B |
| August 19, 2026 | 2.149B |
| August 18, 2026 | 2.033B |
| August 17, 2026 | 2.032B |
| August 14, 2026 | 2.056B |
| August 13, 2026 | 2.018B |
| August 12, 2026 | 2.053B |
| August 11, 2026 | 2.043B |
| August 10, 2026 | 2.053B |
| August 07, 2026 | 2.107B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.144B |
| August 05, 2026 | 2.019B |
| August 04, 2026 | 1.984B |
| August 03, 2026 | 1.905B |
| July 31, 2026 | 1.946B |
| July 30, 2026 | 1.962B |
| July 29, 2026 | 1.985B |
| July 28, 2026 | 1.956B |
| July 27, 2026 | 1.990B |
| July 24, 2026 | 2.007B |
| July 23, 2026 | 1.993B |
| July 22, 2026 | 2.005B |
| July 21, 2026 | 2.045B |
| July 20, 2026 | 1.994B |
| July 17, 2026 | 2.087B |
| July 16, 2026 | 2.084B |
| July 15, 2026 | 2.105B |
| July 14, 2026 | 2.090B |
| July 13, 2026 | 2.096B |
| July 10, 2026 | 2.064B |
| July 09, 2026 | 2.169B |
| July 08, 2026 | 2.122B |
| July 07, 2026 | 2.121B |
| July 06, 2026 | 2.026B |
| July 02, 2026 | 2.041B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| enGene Therapeutics, Inc. | 120.63M |
| Medicus Pharma Ltd. | 9.783M |
| Xenon Pharmaceuticals, Inc. | 5.675B |
| Psyence Biomedical Ltd. | 12.38M |
| Altimmune, Inc. | 635.93M |
Market Cap Related Metrics
| PE Ratio | 7.038 |
| PS Ratio | 7.046 |
| PEG Ratio | 0.0162 |
| Price to Book Value | 3.480 |
| Price to Free Cash Flow | 12.60 |
| Price | 16.10 |
| Earnings Yield | 14.21% |
| PEGY Ratio | 0.0162 |
| Operating PE Ratio | 15.61 |
| Normalized PE Ratio | 7.038 |